What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Mankind Pharma Limited IPO?

Mankind Pharma Limited IPO has received a total subscription of 15.32 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Mankind Pharma Limited

ListedMainboard

Pharmaceuticals & Healthcare · NSE / BSE

Incorporated in 1991, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products across a wide range of acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory. The company offers over 36 brands such as Manforce, Moxikind-CV, Amlokind-AT, Prega News, and Gudcef, supported by one of the largest distribution networks of medical representatives in India, with over 80% of doctors prescribing its formulations. Ranked 4th in domestic sales in FY2022, Mankind Pharma has received numerous awards, including The Best of Bharat Awards 2022, National Awards for Manufacturing Competitiveness Silver Medal 2021, and recognition for Best Design in Healthcare and performance management excellence.

Price Band

₹1026 – ₹1080

Issue Size

₹4326 Cr

Lot Size

13 shares

GMP

₹180

+16.7%

Est. Listing

₹1260

at current GMP

Subscribed

15.32x

overall

Open

25 Apr 2023

27 Apr 2023

Allotment

4 May 2023

Refund

5 May 2023

Demat Credit

6 May 2023

Listing

9 May 2023

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status

Overall Subscription

15.32x

Total Demand

QIB Multiplier

51.74x

Institutions & Funds

NII / HNI

4.00x

High Net-Worth

Retail (RII)

0.97x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 15.32x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
QIB	7,611,181	393,834,103	51.74x
NIB	5,708,386	22,822,761	4.00x
HNIs(10L +)	3,805,591	20,000,500	5.26x
HNIs (2-10L)	1,902,795	2,822,261	1.48x
RETAIL	13,319,566	12,856,038	0.97x
Total	32,347,519	452,335,663	15.32x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 1.08x

Category	Applications Reserved	Applications Received	Times Subscribed
Retail (RII)	1,078,509	1,046,154	0.97x
HNIs (10L +)	6,899	27,596	4.00x
HNIs (2-10L)	33,016	132,064	4.00x
Total Applications	1,118,424	1,205,814	1.08x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Mankind Pharma Limited Public Issue & Market Profile

Mankind Pharma Limited is bringing an initial public offering (IPO) in the Pharmaceuticals & Healthcare sector with an aggregate issue size of ₹4,326.36 Crores. The shares are offered at a price band of ₹1026 to ₹1080 per equity share on NSE and BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.

Bidding & Quota Instructions:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 13 shares (approx. ₹14,040 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Allotment Reconciliation Schedule:

Allotment reconciliation will be managed by KFin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2023-05-06, while un-allotted funds or UPI block mandates will be released on 2023-05-05.

Frequently Asked Questions

What is Mankind Pharma Limited IPO GMP today?

The latest Grey Market Premium (GMP) for Mankind Pharma Limited IPO is ₹180 per equity share. Based on the upper price band of ₹1026 to ₹1080 per equity share, the estimated listing price is ₹1260 (+16.7% expected listing gain).

What is the expected profit per lot for Mankind Pharma Limited IPO?

With a lot size of 13 shares and current GMP of ₹180, the expected profit per application lot is approx ₹2,340 (+16.7% gain). Minimum application cost is approx ₹14,040.

What is the issue size and price band for Mankind Pharma Limited IPO?

The Mankind Pharma Limited IPO aggregate issue size is ₹4,326.36 Crores with an equity price band set at ₹1026 to ₹1080 per equity share. The retail lot size is 13 shares requiring a minimum capital outlay of approx. ₹14,040.

How can I check Mankind Pharma Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 15.32x (Retail: 0.97x, QIB: 51.74x, NII: 4.00x). You can track live multiples directly on our dedicated subscription page.

Where and when will Mankind Pharma Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (KFin Technologies Limited) and the BSE status verification website on or around 2023-05-04. Investors can verify status using PAN card or application number.

When is the listing date for Mankind Pharma Limited IPO?

Mankind Pharma Limited shares are scheduled to list on NSE and BSE on 2023-05-09.